• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝母细胞瘤癌症干细胞表达程序性死亡受体 1(PD-L1),具有可塑性且可在化疗后出现。

Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy.

作者信息

Lee-Theilen Mieun, Fadini Delaine D, Hadhoud Julia R, van Dongen Fleur, Kroll Gabriela, Rolle Udo, Fiegel Henning C

机构信息

Department of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.

出版信息

Cancers (Basel). 2022 Nov 25;14(23):5825. doi: 10.3390/cancers14235825.

DOI:10.3390/cancers14235825
PMID:36497307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9736435/
Abstract

The biology of cancer stem cells (CSCs) of pediatric cancers, such as hepatoblastoma, is sparsely explored. This is mainly due to the very immature nature of these tumors, which complicates the distinction of CSCs from the other tumor cells. Previously, we identified a CSC population in hepatoblastoma cell lines expressing the CSC markers CD34 and CD90, cell surface Vimentin (csVimentin) and binding of OV-6. In this study, we detected the co-expression of the immune escape factor PD-L1 in the CSC population, whereas the other tumor cells remained negative. FACS data revealed that non-CSCs give rise to CSCs, reflecting plasticity of CSCs and non-CSCs in hepatoblastoma as seen in other tumors. When we treated cells with cisplatin and decitabine, a new CD34OV-6CD90 population emerged that lacked csVimentin and PD-L1 expression. Expression analyses showed that this new CSC subset shared similar pluripotency and EMT features with the already-known CSCs. FACS results further revealed that this subset is also generated from non-CSCs. In conclusion, we showed that hepatoblastoma CSCs express PD-L1 and that the biology of hepatoblastoma CSCs is of a plastic nature. Chemotherapeutic treatment leads to another CSC subset, which is highly chemoresistant and could be responsible for a poor prognosis after postoperative chemotherapy.

摘要

小儿癌症(如肝母细胞瘤)的癌症干细胞(CSCs)生物学研究较少。这主要是由于这些肿瘤非常不成熟,使得区分CSCs与其他肿瘤细胞变得复杂。此前,我们在肝母细胞瘤细胞系中鉴定出一个表达CSC标志物CD34和CD90、细胞表面波形蛋白(csVimentin)以及与OV-6结合的CSC群体。在本研究中,我们检测到免疫逃逸因子PD-L1在CSC群体中共同表达,而其他肿瘤细胞仍为阴性。流式细胞术数据显示,非CSCs可产生CSCs,这反映了肝母细胞瘤中CSCs和非CSCs的可塑性,这在其他肿瘤中也有发现。当我们用顺铂和地西他滨处理细胞时,出现了一个新的CD34OV-6CD90群体,该群体缺乏csVimentin和PD-L1表达。表达分析表明,这个新的CSC亚群与已知的CSCs具有相似的多能性和上皮-间质转化特征。流式细胞术结果进一步显示,这个亚群也由非CSCs产生。总之,我们表明肝母细胞瘤CSCs表达PD-L1,且肝母细胞瘤CSCs的生物学特性具有可塑性。化疗导致另一个CSC亚群的出现,该亚群具有高度化疗抗性,可能是术后化疗预后不良的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/e72cd6f733d3/cancers-14-05825-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/ab615e75b1f4/cancers-14-05825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/c0eeaa00bdd0/cancers-14-05825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/01ab564f54cd/cancers-14-05825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/95f05ad05c0f/cancers-14-05825-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/f6a19df01aa5/cancers-14-05825-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/e72cd6f733d3/cancers-14-05825-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/ab615e75b1f4/cancers-14-05825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/c0eeaa00bdd0/cancers-14-05825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/01ab564f54cd/cancers-14-05825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/95f05ad05c0f/cancers-14-05825-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/f6a19df01aa5/cancers-14-05825-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/9736435/e72cd6f733d3/cancers-14-05825-g006.jpg

相似文献

1
Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy.肝母细胞瘤癌症干细胞表达程序性死亡受体 1(PD-L1),具有可塑性且可在化疗后出现。
Cancers (Basel). 2022 Nov 25;14(23):5825. doi: 10.3390/cancers14235825.
2
Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG.CD34、CD90、OV-6 和细胞表面波形蛋白的共表达定义了肝癌的肿瘤干细胞,其受热休克蛋白 90 抑制剂 17-AAG 的影响。
Cells. 2021 Sep 29;10(10):2598. doi: 10.3390/cells10102598.
3
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.肿瘤干细胞在免疫调控和绕过抗检查点治疗中的作用。
Biomed Pharmacother. 2022 Dec;156:113906. doi: 10.1016/j.biopha.2022.113906. Epub 2022 Oct 25.
4
PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.PD-L1 通过激活 HMGA1 依赖性信号通路促进结直肠癌细胞干细胞的扩增。
Cancer Lett. 2019 May 28;450:1-13. doi: 10.1016/j.canlet.2019.02.022. Epub 2019 Feb 15.
5
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion.STT3 依赖性 PD-L1 在肿瘤干细胞上的积累促进免疫逃逸。
Nat Commun. 2018 May 15;9(1):1908. doi: 10.1038/s41467-018-04313-6.
6
The missing link between cancer stem cells and immunotherapy.癌症干细胞与免疫疗法之间缺失的一环。
Curr Med Res Opin. 2024 Nov;40(11):1963-1984. doi: 10.1080/03007995.2024.2407963. Epub 2024 Oct 11.
7
Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas.甲基胆蒽诱导的肉瘤中干细胞样细胞的鉴定与编辑
Oncoimmunology. 2018 Oct 31;8(1):e1404212. doi: 10.1080/2162402X.2017.1404212. eCollection 2019.
8
Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.癌干细胞标志物(CD44、CD90 和 CD133)的异常表达与肝母细胞瘤患者的疾病进展和生存率降低有关:4 年生存率数据。
Transl Res. 2015 Mar;165(3):396-406. doi: 10.1016/j.trsl.2014.07.009. Epub 2014 Aug 7.
9
Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence.脊索瘤癌干细胞亚群的特征描述可能指导靶向免疫治疗方法以减少疾病复发。
Front Oncol. 2024 Apr 29;14:1376622. doi: 10.3389/fonc.2024.1376622. eCollection 2024.
10
PGE /EP antagonism enhances tumor chemosensitivity by inducing extracellular vesicle-mediated clearance of cancer stem cells.PGE/EP 拮抗剂通过诱导细胞外囊泡介导的肿瘤干细胞清除来增强肿瘤化疗敏感性。
Int J Cancer. 2018 Sep 15;143(6):1440-1455. doi: 10.1002/ijc.31523. Epub 2018 May 2.

引用本文的文献

1
Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy.打破免疫抑制以增强针对癌症干细胞的免疫疗法。
Int J Biol Sci. 2025 Feb 10;21(4):1819-1836. doi: 10.7150/ijbs.101025. eCollection 2025.
2
Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment.癌症干细胞与促肿瘤炎症微环境的关系
Biomedicines. 2023 Jan 11;11(1):189. doi: 10.3390/biomedicines11010189.

本文引用的文献

1
Development of CAR T Cell Therapy in Children-A Comprehensive Overview.儿童嵌合抗原受体T细胞疗法的发展——全面概述
J Clin Med. 2022 Apr 12;11(8):2158. doi: 10.3390/jcm11082158.
2
The role of m6A modification in pediatric cancer.N6-甲基腺苷(m6A)修饰在儿科癌症中的作用。
Biochim Biophys Acta Rev Cancer. 2022 Mar;1877(2):188691. doi: 10.1016/j.bbcan.2022.188691. Epub 2022 Feb 2.
3
Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG.
CD34、CD90、OV-6 和细胞表面波形蛋白的共表达定义了肝癌的肿瘤干细胞,其受热休克蛋白 90 抑制剂 17-AAG 的影响。
Cells. 2021 Sep 29;10(10):2598. doi: 10.3390/cells10102598.
4
Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov.PD-1 和 PD-L1 抑制剂在儿科癌症临床开发中的趋势:对 ClinicalTrials.gov 的分析。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002920.
5
DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.DNMT1 介导的 BEX1 甲基化调控肝癌干细胞特性和肿瘤发生。
J Hepatol. 2021 Nov;75(5):1142-1153. doi: 10.1016/j.jhep.2021.06.025. Epub 2021 Jul 1.
6
Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy.免疫检查点抑制剂在儿科癌症中可能作用的争议:平衡 irAEs 和疗效。
Tumori. 2021 Aug;107(4):276-281. doi: 10.1177/03008916211010214. Epub 2021 Apr 20.
7
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.CRISPR/Cas9 介导的 PIM3 基因敲除抑制人肝癌细胞的肿瘤发生和肿瘤干细胞特性。
Cancer Gene Ther. 2022 May;29(5):558-572. doi: 10.1038/s41417-021-00334-4. Epub 2021 Apr 16.
8
Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy.武装免疫细胞以投入战斗:T细胞和自然杀伤细胞免疫疗法进展的简要历程
Cancers (Basel). 2021 Mar 23;13(6):1481. doi: 10.3390/cancers13061481.
9
PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme.小儿多形性胶质母细胞瘤中PD-L1表达与p53表达相关。
Brain Sci. 2021 Feb 19;11(2):262. doi: 10.3390/brainsci11020262.
10
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha-fetoprotein score: a new prognostic risk factor.在 alpha-fetoprotein 评分范围内接受肝移植的患者肝癌结节数量:一个新的预后危险因素。
Transpl Int. 2021 May;34(5):954-963. doi: 10.1111/tri.13858. Epub 2021 Mar 15.